PROFOUND MEDICAL CORP. Equity
PROFOUND MEDICAL CORP. (PROF) had Equity of $31.18 million as of 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Notes
ifrs-full:Equity · last filed 2024-03-07
- 2019-12-31: Equity 18.66M CAD; Equity as first filed 18.66M CAD.
- 2019-01-01: Equity 26.63M CAD; Equity as first filed 26.79M CAD.
- 2018-12-31: Equity 26.63M CAD.
- 2017-12-31: Equity 14.14M CAD.
CAD
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2019-12-31 | 18.66M CAD 40-F · filed 2021-03-02 | 18.66M CAD 40-F · filed 2020-03-03 |
| 2019-01-01 | 26.63M CAD 40-F · filed 2021-03-02 | 26.79M CAD 40-F · filed 2020-03-03 |
| 2018-12-31 | 26.63M CAD 40-F · filed 2020-03-03 | |
| 2017-12-31 | 14.14M CAD 40-F · filed 2020-03-03 |
USD
| Period end | Equity |
|---|---|
| 2023-12-31 | $31.18M 40-F · filed 2024-03-07 |
| 2022-12-31 | $52.00M 40-F · filed 2024-03-07 |
| 2021-12-31 | $80.62M 40-F · filed 2024-03-07 |
| 2020-12-31 | $97.35M 40-F · filed 2023-03-07 |
| 2019-12-31 | $14.37M 40-F · filed 2022-03-03 |
| 2019-01-01 | $19.52M 40-F · filed 2021-03-02 |
| 2018-12-31 | $19.64M 40-F · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |